Articolul precedent |
Articolul urmator |
![]() |
![]() ![]() |
![]() ANDRONACHI, Nicoleta. Situația prin infecții nosocomiale cu acinetobacter pe modelul unui staționar medical multidisciplinar. In: Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, 21-23 octombrie 2020, Chişinău. Chişinău: USMF, 2020, p. 171. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” 2020 | ||||||
Congresul "Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”" Chişinău, Moldova, 21-23 octombrie 2020 | ||||||
|
||||||
Pag. 171-171 | ||||||
|
||||||
![]() |
||||||
Rezumat | ||||||
Background. Acinetobacter is responsible for an increasing number of hospital acquired infections worldwide and the development of antibiotic multidrug resistance of this bacterium is associated with high morbidity and mortality among critically-ill, especially in intensive care units. Objective of the study. To determine the degree of spread of nosocomial infections caused by Acinetobacter in a multidisciplinary hospital in the Republic of Moldova. Material and Methods. A descriptive, crosssectional epidemiological study was performed on the model of the Republican Clinical Hospital, during the years 2014-2016. Data were collected from the registries of bacteriological investigations of patients with purulent-septic infections. Results. Of the total number of cases detected (127), 82.68% were patients hospitalized in the surgical wards and 17.32% in the therapeutic wards, and 66.14% of them were transferred during hospitalization in the intensive care units. Acinetobacter strains showed, on averages, a resistance of 69.69%, with an increase in 2016 compared to 2014 to: tetracyclines (+38.94%), carbapenems (+21.42%) and fluoroquinolones (+10.64%). Conclusion. High prevalence of antibiotic-resistant strains of Acinetobacter emphasizes the importance of the use of selective antibiotic therapy, based on the results of the antibioticogram, and the strict monitoring of measures to combat nosocomial infections. |
||||||
Cuvinte-cheie nosocomial infection, antibiotic resistance, infecție nosocomială, Rezistenţă la antibiotice |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-125331</cfResPublId> <cfResPublDate>2020</cfResPublDate> <cfStartPage>171</cfStartPage> <cfISBN></cfISBN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/125331</cfURI> <cfTitle cfLangCode='RO' cfTrans='o'>Situația prin infecții nosocomiale cu acinetobacter pe modelul unui staționar medical multidisciplinar</cfTitle> <cfKeyw cfLangCode='RO' cfTrans='o'>nosocomial infection; antibiotic resistance; infecție nosocomială; Rezistenţă la antibiotice</cfKeyw> <cfAbstr cfLangCode='EN' cfTrans='o'><p>Background. Acinetobacter is responsible for an increasing number of hospital acquired infections worldwide and the development of antibiotic multidrug resistance of this bacterium is associated with high morbidity and mortality among critically-ill, especially in intensive care units. Objective of the study. To determine the degree of spread of nosocomial infections caused by Acinetobacter in a multidisciplinary hospital in the Republic of Moldova. Material and Methods. A descriptive, crosssectional epidemiological study was performed on the model of the Republican Clinical Hospital, during the years 2014-2016. Data were collected from the registries of bacteriological investigations of patients with purulent-septic infections. Results. Of the total number of cases detected (127), 82.68% were patients hospitalized in the surgical wards and 17.32% in the therapeutic wards, and 66.14% of them were transferred during hospitalization in the intensive care units. Acinetobacter strains showed, on averages, a resistance of 69.69%, with an increase in 2016 compared to 2014 to: tetracyclines (+38.94%), carbapenems (+21.42%) and fluoroquinolones (+10.64%). Conclusion. High prevalence of antibiotic-resistant strains of Acinetobacter emphasizes the importance of the use of selective antibiotic therapy, based on the results of the antibioticogram, and the strict monitoring of measures to combat nosocomial infections.</p></cfAbstr> <cfAbstr cfLangCode='RO' cfTrans='o'><p>Introducere. Acinetobacter este responsabil pentru un număr tot mai mare de infecții asociate asistenței medicale în întreaga lume, iar dezvoltarea multirezistenței la antibiotice a acestuia este asociată cu o morbiditate și mortalitate înaltă la bolnavii critici, în special în secțiile de terapie intensivă. Scopul lucrării. Determinarea gradului de răspândire a infecțiilor nosocomiale cu Acinetobacter în cadrul unui staționar multidisciplinar din Republica Moldova. Material și Metode. A fost realizat un studiu epidemiologic descriptiv, transversal pe modelul Spitalului Clinic Republican, perioada anilor 20142016. Datele au fost acumulate din registrele investigațiilor bacteriologice ale pacienților cu infecții septico-purulente. Rezultate. Din numărul total de cazuri depistate (127), 82,68% au fost pacienți spitalizați în secțiile chirurgicale și 17,32% – în secțiile terapeutice, iar 66,14% din ei au fost transferați pe parcursul spitalizării în secțiile de reanimare și terapie intensivă. Tulpinile de Acinetobacter au manifestat, în medie, o rezistență de 69,69%, observându-se o creștere a acesteia în anul 2016 comparativ cu 2014 față de: tetracicline (+38,94%), carbapeneme (+21,42%) și fluorochinolone (+10,64%). Concluzii. Nivelul înalt de răspândire a tulpinilor de Acinetobacter rezistente la antibiotice subliniază importanța utilizării tratamentului cu antibiotice selectiv, bazat pe rezultatele antibioticogramei și implementarea unui control strict asupra măsurilor de combatere a infecțiilor nosocomiale.</p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2020T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2020T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-64267</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2020T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-64267</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-64267-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2020T24:00:00</cfStartDate> <cfFamilyNames>Andronachi</cfFamilyNames> <cfFirstNames>Nicoleta</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>